Literature DB >> 28360352

Intracranial venous pressures under conscious sedation and general anesthesia.

Daniel M S Raper1, Thomas J Buell1, Ching-Jen Chen1, Dale Ding1, Robert M Starke2, Kenneth C Liu1,3.   

Abstract

INTRODUCTION: Venous outflow obstruction has been implicated in the pathophysiology of a subset of patients with idiopathic intracranial hypertension (IIH), and venous sinus stenting (VSS) has emerged as an effective treatment. However, the effect of anesthesia on venous sinus pressure measurements is unpredictable. A more thorough understanding of the effect of the level of anesthesia on intracranial venous pressures might help to better define patients who might benefit most from stent placement.
OBJECTIVE: To compare, in a retrospective cohort study, intracranial venous pressures measured under conscious (CS) sedation versus general anesthesia (GA) and to assess the relationship between anesthetic-dependent venous pressures and outcomes after VSS.
METHODS: We performed a retrospective review of a prospectively maintained database to identify patients undergoing angiographic evaluation and VSS for intracranial venous stenosis. Mean venous pressures (MVPs) and trans-stenosis pressure gradients obtained under CS were compared with those measured under GA.
RESULTS: The maximal MVP was significantly lower under GA (19.8 mm Hg) than CS (21.9 mm Hg; p=0.029). The MVPs in the superior sagittal sinus, torcula, and transverse sinus were lower under GA, but were significantly higher in the sigmoid sinus and jugular bulb under GA (p<0.001). The mean trans-stenosis pressure gradient was also significantly lower under GA (8.6 mm Hg) than CS (12.1 mm Hg; p<0.001). Patients with a larger difference between maximum MVP under GA versus CS were more likely to have normalization of the MVP after VSS (p=0.0008).
CONCLUSIONS: Intracranial venous pressures are markedly affected by GA. In order to obtain an accurate measurement of MVPs and trans-stenosis gradients, patients undergoing investigation for IIH should undergo cerebral angiography and venous manometry under CS, which provides more reliable data for outcomes after VSS. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Angiography; Intracranial Pressure; Stenosis; Stent; Vein

Mesh:

Year:  2017        PMID: 28360352     DOI: 10.1136/neurintsurg-2017-012984

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  5 in total

1.  Pressure variations in cerebral venous sinuses of idiopathic intracranial hypertension patients.

Authors:  Srikanth R Boddu; Pierre Gobin; Cristiano Oliveria; Marc Dinkin; Athos Patsalides
Journal:  J Vasc Interv Neurol       Date:  2018-06

2.  Management of idiopathic intracranial hypertension in children utilizing venous sinus stenting.

Authors:  Justin Schwarz; Ali Al Balushi; Sri Sundararajan; Marc Dinkin; Cristiano Oliveira; Jeffrey P Greenfield; Athos Patsalides
Journal:  Interv Neuroradiol       Date:  2020-11-25       Impact factor: 1.610

3.  Venous Sinus Stenting using Transcranial Access for the Treatment of Idiopathic Intracranial Hypertension in a Pediatric Patient.

Authors:  Thomas J Buell; Robert M Starke; Dale Ding; Harry R Hixson; Daniel M S Raper; Ching-Jen Chen; Kenneth C Liu
Journal:  J Neurosci Rural Pract       Date:  2017 Oct-Dec

4.  Resolution of venous pressure gradient in a patient with idiopathic intracranial hypertension after ventriculoperitoneal shunt placement: A proof of secondary cerebral sinovenous stenosis.

Authors:  Thomas Buell; Dale Ding; Daniel Raper; Ching-Jen Chen; Zaid Aljuboori; Davis Taylor; Tony Wang; Natasha Ironside; Robert Starke; Kenneth Liu
Journal:  Surg Neurol Int       Date:  2021-01-13

5.  Venous sinus stenting as a treatment approach in patients with idiopathic intracranial hypertension and encephaloceles.

Authors:  Gerald T Drocton; Alexander Copelan; Laura Eisenmenger; Javier E Villanueva-Meyer; William P Dillon; Vinil N Shah; Karl Meisel; Matthew Amans
Journal:  Interv Neuroradiol       Date:  2020-09-20       Impact factor: 1.610

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.